OEM News

IQVIA, NVIDIA Collaborate on Advanced Agentic AI Solutions

The teamwork will pair IQVIA's information assets, analytics, and domain expertise with the NVIDIA AI Foundry service.

By: Michael Barbella

Managing Editor

IQVIA has formed a strategic partnership with NVIDIA to help realize AI’s potential in healthcare and life sciences.

The two industries generate vast amounts of data, representing significant potential for artificial intelligence (AI)-powered solutions. This collaboration between IQVIA and NVIDIA will help accelerate IQVIA Healthcare-grade AI, enabling new levels of agentic automation of complex and time-consuming workflows across the therapeutic life cycle with precision and scalability. IQVIA ensures its AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety.

“This represents a significant leap forward in how we apply AI to healthcare and life sciences,” said Bhavik Patel, president, Commercial Solutions, IQVIA. “We are excited to combine our capabilities and a decade of experience in artificial intelligence with NVIDIA’s advanced AI technologies. We will build new solutions powered by AI agents trained on healthcare information and optimized for life sciences workflows. This collaboration will advance our mission to help our clients accelerate innovation and treatments to market.”

The collaboration will combine IQVIA’s information assets, analytics, and domain expertise—known as IQVIA Connected Intelligence—with the NVIDIA AI Foundry service to help transform life science processes from R&D through commercialization. This work is poised to create new efficiencies, enable new operating models, and ultimately improve patient outcomes, according to IQVIA.

“By integrating NVIDIA AI Foundry platform and services, IQVIA can enhance its Healthcare-grade AI solutions to create custom, domain-specific models and agents for thousands of complex workflows needed in healthcare and life sciences,” said Kimberly Powell, vice president of Healthcare, NVIDIA. “AI agents can become digital companions to researchers, doctors and patients, helping unlock enormous productivity and expanding access to care globally.”

IQVIA will work with NVIDIA to develop and optimize AI agents with initial solutions expected to reach market within the calendar year. The collaboration includes access to NVIDIA NIM microservices, NVIDIA NeMo and the NVIDIA DGX Cloud platform, as well as direct support from NVIDIA’s research and engineering teams. Additionally, the collaboration will be deploying the NVIDIA AI Blueprint for multi-modal data extraction to enable access to useful information previously inaccessible to AI models and agents.

IQVIA provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in more than 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters